Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00080015
Status:
COMPLETED
Last Update Posted:
2020-04-29
First Post:
2004-03-19
Brief Title:
Diflomotecan BN80915 Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer SCLC
Sponsor:
Ipsen
Organization:
Ipsen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-03-12
Start Date Type:
ACTUAL
Primary Completion Date:
2005-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-02
Completion Date Type:
ACTUAL
First Submit Date:
2004-03-19
First Submit QC Date:
March 22 2004
Study First Post Date:
2004-03-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-27
Last Update Post Date:
2020-04-29
Last Update Post Date Type:
ACTUAL